- Home
- / Neptunus
Neptunus
Stock Price
$0.1
2024-10-29
Market Capitalization
$226.5 M
2024-10-29
Revenue
¥1.1 B
FY, 2023
Neptunus Summary
Company Summary
- Overview
- Neptunus is a biotechnology company that produces and distributes medicines. Its products include herbal medicines, transfusion and antitumor drugs, in-vitro diagnostic reagents, etc. The company offers research and development, and sales services.
- Type
- Public
- Status
- Active
- Founded
- 1989
- HQ
- Shen Zhen Shi, CN | view all locations
- Website
- http://www.interlong.com
- Cybersecurity rating
- Sectors
Table of Contents
LocationsView all
1 location detected
Shen Zhen Shi, Guang Dong Sheng HQ
China
Xiang Gang Li Gong Da Xue Chan Xue Yan Da Lou, 科技园 Nan Shan Qu
Neptunus Financials
Summary Financials
- Revenue (H1, 2024)
- ¥544.5M
- Gross profit (H1, 2024)
- ¥212.5M
- Net income (H1, 2024)
- ¥41.3M
- Cash (H1, 2024)
- ¥311.9M
- EBIT (H1, 2024)
- ¥50.4M
- Enterprise value
- $26.7M
Footer menu
Product
- Intelligence Suite
- Supplier Intelligence Platform
- Craft Intelligence Portal
- Craft API
- Craft for Teams
- Supplier Intelligence Platform
- Craft Alerts
- Craft N-Tier Mapping
- Craft Risk Hub
- Chrome extension
Resources
© Craft.co 2025